Byron Nash Renal Medullary Carcinoma Awareness Act of 2023

Cost and committee reports

Official records Congress.gov attaches to H.R. 124.

• Constitutional authority statementThe sponsor’s statement of where the Constitution gives Congress the power to pass this bill. Statement by Mr. GREEN of Texas, as printed in the Congressional Record (Vol. 171, No. 1, January 3, 2025, Page H40):
  Necessary and Proper Clause (Art. 1, Sec. 8, Cl. 18) The single subject of this legislation is: To amend title XIX of the Social Security Act to provide incentives for education on the risk of renal medullary carcinoma in individuals who are receiving medical assistance under such title and who have sickle cell disease.
  Source: Congress.gov, Congressional Record January 3, 2025 ↗

  Evidence

  Field in the Congress.gov record

  constitutionalAuthorityStatementText

  Statement length

  321 characters

  Congress.gov bill record

  H.R. 124, 119th Congress

  Congress.gov API record

  https://api.congress.gov/v3/bill/119/hr/124

  Record last updated by Congress.gov

  March 19, 2025

  PORKER copy retrieved

  September 13, 2026

  Stored copy, SHA-256 of the file

  90c65d2b7e73ebacd7dab239bdb1d076b19b64412b041ac1bae8b3d585d49554

  PORKER shows the statement exactly as printed, with the page markup removed. It is the sponsor’s claim; it is not a legal finding.

Congress.gov’s record for this bill does not list a CBO cost estimate or a committee report (as of March 19, 2025). Not every bill gets one.

From the Congress.gov bill record for H.R. 124, last updated March 19, 2025. PORKER’s copy was retrieved September 13, 2026 and is refreshed nightly. Open “Evidence” on any line for the record, field and file fingerprint.